In a tissue-based study conducted by Kim et al., it was found that 25% (9/36) of HCC tissues exhibited missense mutations in AXIN1, and 66.7% (24/36) exhibited reduced or absent AXIN1 expression. This evidence concerns the gene AXIN1 and hepatocellular carcinoma.